Editas Medicine (EDIT) EBITDA Margin Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) EBITDA Margin Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.66 Mn |
| Jun 30, 2025 | -58,811.00 |
| Mar 31, 2025 | -88,558.00 |
| Dec 31, 2024 | 18,146.00 |
| Sep 30, 2024 | -10.70 Mn |
| Jun 30, 2024 | 60,150.00 |
| Mar 31, 2024 | -502,703.00 |
| Dec 31, 2023 | 53,696.00 |
| Sep 30, 2023 | -95,439.00 |
| Jun 30, 2023 | -123,578.00 |
| Mar 31, 2023 | 29,722.00 |
| Dec 31, 2022 | -64,979.00 |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | 67,753.00 |
| Mar 31, 2022 | 76,145.00 |
| Dec 31, 2021 | 9,533.00 |
| Sep 30, 2021 | -52,144.00 |
| Jun 30, 2021 | -1.41 Mn |
| Mar 31, 2021 | -7,162.00 |
| Sep 30, 2020 | 84,415.00 |